Detalhe da pesquisa
1.
Intraputamenal Cerebral Dopamine Neurotrophic Factor in Parkinson's Disease: A Randomized, Double-Blind, Multicenter Phase 1 Trial.
Mov Disord;
38(7): 1209-1222, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37212361
2.
Patients accept therapy using embryonic stem cells for Parkinson's disease: a discrete choice experiment.
BMC Med Ethics;
24(1): 83, 2023 10 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37828462
3.
Patients' views on using human embryonic stem cells to treat Parkinson's disease: an interview study.
BMC Med Ethics;
23(1): 102, 2022 10 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36261826
4.
Attitudes and values among the Swedish general public to using human embryonic stem cells for medical treatment.
BMC Med Ethics;
23(1): 138, 2022 12 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36550460
5.
Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain.
Proc Natl Acad Sci U S A;
113(23): 6544-9, 2016 06 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27140603
6.
11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.
Mov Disord;
33(1): 117-127, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29082547
7.
Alteration of putaminal fractional anisotropy in Parkinson's disease: a longitudinal diffusion kurtosis imaging study.
Neuroradiology;
60(3): 247-254, 2018 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29368035
8.
Aberrant nigral diffusion in Parkinson's disease: A longitudinal diffusion tensor imaging study.
Mov Disord;
31(7): 1020-6, 2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27104232
9.
Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.
Brain;
138(Pt 4): 963-73, 2015 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25669730
10.
Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy.
Neuroradiology;
57(11): 1079-91, 2015 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26253801
11.
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD.
Cell Stem Cell;
30(10): 1299-1314.e9, 2023 10 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37802036
12.
Development and Validation of a Prognostic Model to Predict Overall Survival in Multiple System Atrophy.
Mov Disord Clin Pract;
10(9): 1368-1376, 2023 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37772304
13.
Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers.
Neuroepidemiology;
38(3): 186-93, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22472568
14.
Insights on Genetic and Environmental Factors in Parkinson's Disease from a Regional Swedish Case-Control Cohort.
J Parkinsons Dis;
12(1): 153-171, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34776419
15.
[Recurrent psychotic symtoms over several years were caused by Huntington's disease]. / Återkommande psykotiska symtom under många år var Huntingtons sjukdom.
Lakartidningen;
1182021 01 19.
Artigo
em Sueco
| MEDLINE
| ID: mdl-33474718
16.
Genetically Targeted Clinical Trials in Parkinson's Disease: Learning from the Successes Made in Oncology.
Genes (Basel);
12(10)2021 09 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34680924
17.
Transforming trash to treasure Cultural ambiguity in foetal cell research.
Philos Ethics Humanit Med;
16(1): 6, 2021 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34521443
18.
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
Mov Disord;
25(8): 1091-6, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20198645
19.
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
Mov Disord;
25(15): 2604-12, 2010 Nov 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20922810
20.
[Parkinson's disease - heterogeneous and complex in its clinical presentation]. / Parkinsons sjukdom heterogen och komplex i sitt kliniska uttryck - Individuella kombinationer av symtom som ändrar sig över tid kräver behandlingsjusteringar och anpassningar.
Lakartidningen;
1172020 03 09.
Artigo
em Sueco
| MEDLINE
| ID: mdl-32154902